penicillin g has been researched along with Pneumonia, Bacterial in 31 studies
Penicillin G: A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission.
benzylpenicillin : A penicillin in which the substituent at position 6 of the penam ring is a phenylacetamido group.
Pneumonia, Bacterial: Inflammation of the lung parenchyma that is caused by bacterial infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sepsis is a common cause of morbidity and mortality." | 5.29 | Granulocyte colony-stimulating factor versus placebo in addition to penicillin G in a randomized blinded study of gram-negative pneumonia sepsis: analysis of survival and multisystem organ failure. ( Millard, FE; Samuelson, D; Sharpe, RW; Smith, WS; Sumnicht, GE, 1995) |
| "We present the first case of mediastinitis and the third case of pneumonia attributed to Actinomyces odontolyticus." | 2.39 | Actinomyces odontolyticus thoracopulmonary infections. Two cases in lung and heart-lung transplant recipients and a review of the literature. ( Bassiri, AG; Girgis, RE; Theodore, J, 1996) |
| "Penicillin G successfully treated 82% (126/154) of the study group and improvement was marked on the first day of treatment." | 1.37 | Outcome of children hospitalized with community-acquired pneumonia treated with aqueous penicillin G. ( Araújo, M; Nascimento-Carvalho, CM; Simbalista, R, 2011) |
| "Inhalation anthrax is a rare and almost uniformly fatal form of human anthrax caused by the inhalation of spores of Bacillus anthracis." | 1.30 | Anthrax pneumonia. ( Klotz, SA; Penn, CC, 1997) |
| "Infection of a chylothorax is thought not to occur because chyle is inherently bacteriostatic." | 1.30 | Infected spontaneous chylothorax. ( Hadeli, O; Natrajan, S; Quan, SF, 1998) |
| "Sepsis is a common cause of morbidity and mortality." | 1.29 | Granulocyte colony-stimulating factor versus placebo in addition to penicillin G in a randomized blinded study of gram-negative pneumonia sepsis: analysis of survival and multisystem organ failure. ( Millard, FE; Samuelson, D; Sharpe, RW; Smith, WS; Sumnicht, GE, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.23) | 18.7374 |
| 1990's | 12 (38.71) | 18.2507 |
| 2000's | 9 (29.03) | 29.6817 |
| 2010's | 8 (25.81) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Gou, S | 1 |
| Li, B | 1 |
| Ouyang, X | 1 |
| Ba, Z | 1 |
| Zhong, C | 1 |
| Zhang, T | 1 |
| Chang, L | 1 |
| Zhu, Y | 1 |
| Zhang, J | 1 |
| Zhu, N | 1 |
| Zhang, Y | 1 |
| Liu, H | 1 |
| Ni, J | 1 |
| Brandão, A | 1 |
| Simbalista, R | 2 |
| Borges, IC | 1 |
| Andrade, DC | 1 |
| Araújo, M | 2 |
| Nascimento-Carvalho, CM | 2 |
| Qazi, SA | 1 |
| Fox, MP | 1 |
| Thea, DM | 1 |
| Agweyu, A | 2 |
| Gathara, D | 1 |
| Oliwa, J | 1 |
| Muinga, N | 1 |
| Edwards, T | 1 |
| Allen, E | 1 |
| Maleche-Obimbo, E | 1 |
| English, M | 2 |
| Lorgelly, PK | 1 |
| Atkinson, M | 2 |
| Lakhanpaul, M | 2 |
| Smyth, AR | 1 |
| Vyas, H | 2 |
| Weston, V | 2 |
| Stephenson, T | 2 |
| Opiyo, N | 1 |
| Korppi, M | 1 |
| Schwab, J | 1 |
| Lantos, J | 1 |
| Tanz, RR | 1 |
| Meadow, W | 1 |
| FLIPPIN, HF | 1 |
| BARTHOLOMEW, LE | 1 |
| MATTEUCCI, WV | 1 |
| SCHIMMEL, NH | 1 |
| Cetinkaya, F | 1 |
| Gogremis, A | 1 |
| Kutluk, G | 1 |
| David, G | 1 |
| Perpoint, T | 1 |
| Boibieux, A | 1 |
| Pialat, JB | 1 |
| Salord, H | 1 |
| Devouassoux, M | 1 |
| Chidiac, C | 1 |
| Peyramond, D | 1 |
| Soler V, T | 1 |
| Salamanca F, L | 1 |
| Molina, E | 1 |
| Mankhambo, LA | 1 |
| Chiwaya, KW | 1 |
| Phiri, A | 1 |
| Graham, SM | 1 |
| Smyth, A | 1 |
| Sithole, J | 1 |
| Owen, V | 1 |
| Halliday, K | 1 |
| Sammons, H | 1 |
| Crane, J | 1 |
| Guntupalli, N | 1 |
| Walton, L | 1 |
| Ninan, T | 1 |
| Morjaria, A | 1 |
| Smith, WS | 1 |
| Sumnicht, GE | 1 |
| Sharpe, RW | 1 |
| Samuelson, D | 1 |
| Millard, FE | 1 |
| Bohte, R | 1 |
| van't Wout, JW | 1 |
| Lobatto, S | 1 |
| Blussé van Oud Alblas, A | 1 |
| Boekhout, M | 1 |
| Nauta, EH | 1 |
| Hermans, J | 1 |
| van den Broek, PJ | 1 |
| Gaillat, J | 1 |
| Bru, JP | 1 |
| Sedallian, A | 1 |
| Hamour, A | 1 |
| Bonnington, A | 1 |
| Wilkins, EG | 1 |
| Regamey, C | 1 |
| Cuadrado-Gómez, LM | 1 |
| Arranz-Caso, JA | 1 |
| Cuadros-González, J | 1 |
| Albarrán-Hernández, F | 1 |
| Bassiri, AG | 1 |
| Girgis, RE | 1 |
| Theodore, J | 1 |
| Penn, CC | 1 |
| Klotz, SA | 1 |
| Natrajan, S | 1 |
| Hadeli, O | 1 |
| Quan, SF | 1 |
| Léophonte, P | 1 |
| Sherer, Y | 1 |
| Bakshi, E | 1 |
| Rotman, P | 1 |
| Levy, Y | 1 |
| Shoenfeld, Y | 1 |
| Tsai, WC | 1 |
| Rosón, B | 1 |
| Carratalà, J | 1 |
| Tubau, F | 1 |
| Dorca, J | 1 |
| Liñares, J | 1 |
| Pallares, R | 1 |
| Manresa, F | 1 |
| Gudiol, F | 1 |
| Allewelt, M | 1 |
| Lode, H | 1 |
| Miyake, S | 1 |
| Sawabe, E | 1 |
| Inase, N | 1 |
| Yoshizawa, Y | 1 |
| Nijs, A | 1 |
| Vandekerkhof, J | 1 |
| Cartuyvels, R | 1 |
| Magerman, K | 1 |
| Mewis, A | 1 |
| Peeters, V | 1 |
| Rummens, JL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Amoxicillin Versus Benzyl Penicillin for Severe Childhood Pneumonia Amongst Inpatients: An Open Label Randomised Controlled Non-inferiority Trial[NCT01399723] | Phase 3 | 561 participants (Actual) | Interventional | 2011-09-30 | Completed | ||
| Ceftriaxone Versus Chloramphenicol for Treatment of Severe Pneumonia in Children Aged Less Than Five Years at Mulago Hospital: A Randomized Controlled Trial[NCT00372541] | Phase 3 | 348 participants (Anticipated) | Interventional | 2006-09-30 | Completed | ||
| Assessing the Feasibility and Effectiveness of Introducing Pulse Oximetry in IMCI Services to Manage Acute Respiratory Infections at First Level Health Facilities of Bangladesh[NCT03750747] | 612 participants (Anticipated) | Interventional | 2018-12-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Definition of death as described in third secondary outcome measure. (NCT01399723)
Timeframe: Day 14
| Intervention | participants (Number) |
|---|---|
| Amoxicillin | 33 |
| Penicillin | 42 |
Development of any signs of very severe pneumonia at any time Hypoxemia defined as SpO2 <85% or <80% for altitude < or ≥1500m respectively measured after minimum of 3 minutes on ambient air Persistent vomiting (occurring within 30 minutes of administration of amoxicillin with failure to retain drug after 3 successive attempts at administration) at any time Clinical diagnosis of new bacterial co-morbid condition requiring revision of antibiotic treatment at any time Lower chest wall indrawing Temperature ≥38◦C Respiratory rate ≥5bpm of admission rate if above age-adjusted normal upper limit (NCT01399723)
Timeframe: 48 hours
| Intervention | participants (Number) |
|---|---|
| Amoxicillin | 20 |
| Penicillin | 21 |
Treatment failure as defined in the primary outcome measure. (NCT01399723)
Timeframe: Patients will be followed up from the day of hospitalisation (day 0) until the day of medical discharge (average duration of 3 days) or until day 5 of hospitalisation (whichever occurs first).
| Intervention | participants (Number) |
|---|---|
| Amoxicillin | 30 |
| Penicillin | 29 |
6 reviews available for penicillin g and Pneumonia, Bacterial
| Article | Year |
|---|---|
Experience developing national evidence-based clinical guidelines for childhood pneumonia in a low-income setting--making the GRADE?
Topics: Amoxicillin; Ceftriaxone; Child; Developing Countries; Evidence-Based Medicine; Gentamicins; Humans; | 2012 |
Secondary pulmonary syphilis: report of a likely case and literature review.
Topics: Adult; Anti-Bacterial Agents; HIV Infections; Humans; Male; Penicillin G; Pneumonia, Bacterial; Syph | 2006 |
[Various new pathogens in pneumonia].
Topics: Chlamydophila pneumoniae; Humans; Orthohantavirus; Penicillin G; Penicillin Resistance; Pneumonia, B | 1995 |
Actinomyces odontolyticus thoracopulmonary infections. Two cases in lung and heart-lung transplant recipients and a review of the literature.
Topics: Actinomycosis; Administration, Oral; Adult; Debridement; Heart-Lung Transplantation; Humans; Injecti | 1996 |
[Bacterial pneumonia].
Topics: Ampicillin; Drug Resistance; Haemophilus Infections; Haemophilus influenzae; Humans; Japan; Penicill | 2002 |
Streptococcus pneumoniae-infected aneurysm extending from a persistent lobar pneumonia: case report and review of the literature.
Topics: Aged; Aneurysm, Infected; Aorta, Abdominal; Humans; Male; Penicillin G; Penicillins; Pneumococcal In | 2002 |
7 trials available for penicillin g and Pneumonia, Bacterial
| Article | Year |
|---|---|
Oral amoxicillin versus benzyl penicillin for severe pneumonia among kenyan children: a pragmatic randomized controlled noninferiority trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Child, Preschool; Female; Humans; Infant; Kenya; Male; Penicilli | 2015 |
Oral versus i.v. antibiotics for community-acquired pneumonia in children: a cost-minimisation analysis.
Topics: Administration, Oral; Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Hospitalized; Ch | 2010 |
Comparison of two antibiotic regimens in the empirical treatment of severe childhood pneumonia.
Topics: Ceftriaxone; Child, Hospitalized; Child, Preschool; Chloramphenicol; Community-Acquired Infections; | 2004 |
Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Child, Preschool; Community-Acquired Infec | 2007 |
Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia.
Topics: Administration, Oral; Adult; Aged; Azithromycin; Community-Acquired Infections; Erythromycin; Female | 1995 |
Penicillin G/ofloxacin versus erythromycin/amoxicillin-clavulanate in the treatment of severe community-acquired pneumonia.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acids; Community | 1994 |
Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactam Resistance; | 2001 |
18 other studies available for penicillin g and Pneumonia, Bacterial
| Article | Year |
|---|---|
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Line; C | 2021 |
Retrospective analysis of the efficacies of two different regimens of aqueous penicillin G administered to children with pneumonia.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Community-Acquired Infections; Drug Administration S | 2014 |
Editorial commentary: ambulatory management of chest-indrawing pneumonia.
Topics: Amoxicillin; Anti-Bacterial Agents; Female; Humans; Male; Penicillin G; Pneumonia, Bacterial | 2015 |
Outcome of children hospitalized with community-acquired pneumonia treated with aqueous penicillin G.
Topics: Anti-Bacterial Agents; Brazil; Child; Child, Preschool; Cohort Studies; Community-Acquired Infection | 2011 |
Diagnosis and treatment of community-acquired pneumonia in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Community-Acquired Infections; Finland; Humans; Lung; Pen | 2012 |
Editors' comments.
Topics: Amoxicillin; Anti-Bacterial Agents; Humans; Penicillin G; Penicillin V; Pneumonia, Bacterial; Pneumo | 2012 |
The hydriodide of diethylaminoethyl ester of penicillin G, neo-penil. V. A comparative study of the treatment of bacterial pneumonias with procaine penicillin.
Topics: Esters; Penicillin G; Penicillin G Procaine; Penicillins; Pneumonia; Pneumonia, Bacterial | 1953 |
[In vitro antimicrobial susceptibility of anaerobic bacteria isolated from pleuropulmonary infections].
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroidaceae Infections; Chloram | 2006 |
Lobar pneumonia caused by nontyphoidal Salmonella in a Malawian child.
Topics: Anti-Bacterial Agents; Ceftriaxone; Female; Gentamicins; HIV Infections; Hospitalization; Humans; In | 2006 |
Granulocyte colony-stimulating factor versus placebo in addition to penicillin G in a randomized blinded study of gram-negative pneumonia sepsis: analysis of survival and multisystem organ failure.
Topics: Animals; Double-Blind Method; Female; Granulocyte Colony-Stimulating Factor; Hemoglobins; Leukocyte | 1995 |
Severe community acquired pneumonia associated with a desquamating rash due to group A beta-haemolytic streptococcus.
Topics: Community-Acquired Infections; Humans; Male; Middle Aged; Penicillin G; Pleural Effusion; Pneumonia, | 1994 |
Pasteurella pneumotropica pneumonia in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Bronchoalveolar Lavage Fluid; Humans; Male; Pasteurella; | 1995 |
Anthrax pneumonia.
Topics: Animals; Animals, Domestic; Anthrax; Diagnosis, Differential; Humans; Occupational Exposure; Penicil | 1997 |
Infected spontaneous chylothorax.
Topics: Adult; Chylothorax; Humans; Immunocompromised Host; Kidney Transplantation; Male; Penicillin G; Peni | 1998 |
[Management of community-acquired pneumopathies of adults in the city and at the hospital].
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalospo | 1998 |
Comparative clinical study of cefonicid, chloramphenicol, and penicillin in community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Blood Cell Count; Cefonicid; Chloramphenicol; Community-Acquired Infections; | 1998 |
Meningococcal pneumonia: a case report.
Topics: Adult; Humans; Male; Meningococcal Infections; Penicillin G; Pneumonia, Bacterial | 1998 |
[Diagnosis and therapy of abscess forming pneumonia].
Topics: Diagnosis, Differential; Drug Therapy, Combination; Humans; Lung Abscess; Microbial Sensitivity Test | 2001 |